Lidocaine pre-treatment for Succinylcholine induced postoperative myalgia and associated factors: Longitudinal study

IF 1.4 Q3 SURGERY
Fassil Mihretu , Telake Azale , Foziya Mohammed , Amare Agumas , Sara Timerga , Aynalem Befikadu
{"title":"Lidocaine pre-treatment for Succinylcholine induced postoperative myalgia and associated factors: Longitudinal study","authors":"Fassil Mihretu ,&nbsp;Telake Azale ,&nbsp;Foziya Mohammed ,&nbsp;Amare Agumas ,&nbsp;Sara Timerga ,&nbsp;Aynalem Befikadu","doi":"10.1016/j.sopen.2024.09.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Postoperative myalgia in surgical patients is mainly caused by the routinely administered depolarizing muscle relaxant, Succinylcholine. There are many proposed strategies but no one were indicated as ideal preventive mechanisms for Succinylcholine induced post-operative myalgia. Even if data were sparse, Lidocaine pretreatment can reduce postoperative myalgia which requires further supportive evidences urging the initiation of this study.</div></div><div><h3>Methods</h3><div>Prospective longitudinal cohort study was conducted from March to May 2021 at Dessie Comprehensive Specialized Hospital on 208 adult surgical patients. Patients pretreated with Lidocaine preoperatively were grouped as exposed and others as unexposed. Patients meeting the inclusion criteria during the study period were selected sequentially from the daily operation schedule list. Postoperative myalgia level was measured using post-operative myalgia survey repeatedly. The result was analyzed by Cochran's Q test and generalized estimating equation (GEE). Adjusted odds ratio with 95 % confidence interval and <em>p</em> value &lt; 0.05 was used to show the difference, direction and strength of association.</div></div><div><h3>Result</h3><div>Exposure specific incidence rate showed that 22 %, 22 % and 29.8 % of patients exposed to Lidocaine and 40.6 %, 42.7 % and 34 % not exposed to Lidocaine developed myalgia at 12, 24, and 48 h respectively. There is no significant difference in the incidence of myalgia over time between the repeated measurements in Lidocaine exposed patients (<em>p</em> = 0.513) but in non-exposed patients (<em>p</em> = 0.003). Also, there is no difference in the distribution of other predictors between Lidocaine exposed and non-exposed groups (<em>p</em> &gt; 0.05). Exposure to Lidocaine reduces postoperative myalgia significantly [AOR = 0.33, 95 % CI = (0.17,0.66)]. Multimodal analgesia [AOR = 0.32, 95 % CI = (0.18,0.55)], non-steroidal anti-inflammatory drugs alone [AOR = 0.47, 95 % CI = (0.29,0.76)], postoperative immobility [AOR = 0.61, 95 % CI = (0.47,0.8)], and being male [AOR = 0.48, 95 % CI = (0.26,0.87)] were other determinants in reducing Succinylcholine induced postoperative myalgia.</div></div><div><h3>Conclusion</h3><div>Lidocaine pretreatment can significantly reduce the occurrence of Succinylcholine induced postoperative myalgia. Additionally, usage of multimodal analgesia with non-steroidal anti-inflammatory drugs or even only non-steroidal anti-inflammatory drugs in the intraoperative and postoperative period can reduce Succinylcholine induced postoperative myalgia.</div></div>","PeriodicalId":74892,"journal":{"name":"Surgery open science","volume":"21 ","pages":"Pages 45-51"},"PeriodicalIF":1.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589845024001180/pdfft?md5=21859384b67984b733588bdadcf7520e&pid=1-s2.0-S2589845024001180-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery open science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589845024001180","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Postoperative myalgia in surgical patients is mainly caused by the routinely administered depolarizing muscle relaxant, Succinylcholine. There are many proposed strategies but no one were indicated as ideal preventive mechanisms for Succinylcholine induced post-operative myalgia. Even if data were sparse, Lidocaine pretreatment can reduce postoperative myalgia which requires further supportive evidences urging the initiation of this study.

Methods

Prospective longitudinal cohort study was conducted from March to May 2021 at Dessie Comprehensive Specialized Hospital on 208 adult surgical patients. Patients pretreated with Lidocaine preoperatively were grouped as exposed and others as unexposed. Patients meeting the inclusion criteria during the study period were selected sequentially from the daily operation schedule list. Postoperative myalgia level was measured using post-operative myalgia survey repeatedly. The result was analyzed by Cochran's Q test and generalized estimating equation (GEE). Adjusted odds ratio with 95 % confidence interval and p value < 0.05 was used to show the difference, direction and strength of association.

Result

Exposure specific incidence rate showed that 22 %, 22 % and 29.8 % of patients exposed to Lidocaine and 40.6 %, 42.7 % and 34 % not exposed to Lidocaine developed myalgia at 12, 24, and 48 h respectively. There is no significant difference in the incidence of myalgia over time between the repeated measurements in Lidocaine exposed patients (p = 0.513) but in non-exposed patients (p = 0.003). Also, there is no difference in the distribution of other predictors between Lidocaine exposed and non-exposed groups (p > 0.05). Exposure to Lidocaine reduces postoperative myalgia significantly [AOR = 0.33, 95 % CI = (0.17,0.66)]. Multimodal analgesia [AOR = 0.32, 95 % CI = (0.18,0.55)], non-steroidal anti-inflammatory drugs alone [AOR = 0.47, 95 % CI = (0.29,0.76)], postoperative immobility [AOR = 0.61, 95 % CI = (0.47,0.8)], and being male [AOR = 0.48, 95 % CI = (0.26,0.87)] were other determinants in reducing Succinylcholine induced postoperative myalgia.

Conclusion

Lidocaine pretreatment can significantly reduce the occurrence of Succinylcholine induced postoperative myalgia. Additionally, usage of multimodal analgesia with non-steroidal anti-inflammatory drugs or even only non-steroidal anti-inflammatory drugs in the intraoperative and postoperative period can reduce Succinylcholine induced postoperative myalgia.
利多卡因预处理治疗琥珀胆碱诱发的术后肌痛及其相关因素:纵向研究
导言 手术患者术后肌痛主要是由常规使用的去极化肌肉松弛剂琥珀酰胆碱引起的。针对琥珀酰胆碱引起的术后肌痛,有许多建议的策略,但没有一种是理想的预防机制。即使数据稀少,利多卡因预处理也能减轻术后肌痛,这需要进一步的支持性证据,因此需要启动这项研究。方法 2021 年 3 月至 5 月,德西综合专科医院对 208 名成年手术患者进行了前瞻性纵向队列研究。将术前使用利多卡因的患者分为暴露组和未暴露组。研究期间,符合纳入标准的患者按顺序从每日手术时间表列表中选出。使用术后肌痛调查表反复测量术后肌痛程度。结果通过 Cochran's Q 检验和广义估计方程(GEE)进行分析。结果暴露特异性发病率显示,在 12、24 和 48 小时内,分别有 22 %、22 % 和 29.8 % 的暴露利多卡因的患者和 40.6 %、42.7 % 和 34 % 未暴露利多卡因的患者出现肌痛。在重复测量中,暴露于利多卡因的患者肌痛发生率随时间变化无明显差异(p = 0.513),而未暴露于利多卡因的患者肌痛发生率随时间变化无明显差异(p = 0.003)。此外,利多卡因暴露组和非暴露组之间的其他预测因子分布也没有差异(p > 0.05)。使用利多卡因可显著减轻术后肌痛[AOR = 0.33, 95 % CI = (0.17,0.66)]。多模式镇痛[AOR = 0.32,95 % CI = (0.18,0.55)]、单独使用非甾体抗炎药[AOR = 0.47,95 % CI = (0.29,0.76)]、术后不移动[AOR = 0.61,95 % CI = (0.47,0.8)]和男性[AOR = 0.结论 利多卡因预处理可显著减少琥珀胆碱诱发的术后肌痛的发生。此外,在术中和术后使用非甾体类抗炎药甚至仅使用非甾体类抗炎药的多模式镇痛可减少琥珀胆碱诱发的术后肌痛。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.30
自引率
0.00%
发文量
0
审稿时长
66 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信